PVG Asset Management’s AstraZeneca AZN Stock Holding History

PVG Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-34,983	Closed	-$2.37M	–	80
2017 Q3	$2.37M	Sell	34,983 -3,890	-10%	-$246K	1.04%	28
2017 Q2	$2.65M	Sell	38,873 -93,465	-71%	-$6.1M	1%	32
2017 Q1	$8.24M	Buy	132,338 +24,170	+22%	+$1.41M	2.55%	9
2016 Q4	$5.91M	Buy	108,168 +69,774	+182%	+$3.96M	2.49%	8
2016 Q3	$2.52M	Buy	38,394 +534	+1%	+$34.9K	1.07%	27
2016 Q2	$2.29M	Sell	37,860 -40,139	-51%	-$2.33M	0.95%	38
2016 Q1	$4.39M	Buy	+77,999	New	+$4.69M	1.72%	19

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVG Asset Management's AZN Position: Q4 2017 in Review

PVG Asset Management sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 34,983 shares — an estimated $2.37M sold.

PVG Asset Management first reported a position in AZN in Q1 2016 and held it in 7 quarters. The position peaked at $8.24M in Q1 2017. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

PVG Asset Management reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
PVG Asset Management sold 34,983 AstraZeneca shares in Q4 2017, an estimated $2.37M.
PVG Asset Management first reported a position in AstraZeneca in Q1 2016 and held it in 7 quarters.
PVG Asset Management's AstraZeneca position peaked at $8.24M in Q1 2017.
503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on PVG Asset Management's 13F filing for Q4 2017, filed 15 Feb 2018.